Fog Pharmaceuticals

Developer of cell-penetrating mini-proteins to target intracellular disease drivers

placeBoston, Massachusetts, United States calendar_todayFounded 2015 groups97 employees language fogpharma.com

Registered entities

Social engagement

Social engagement: 19K social following, 10 posts in the last 12 months — above the industry median.

Investor mix

27 investors on record; lead investors include 6 Dimensions Capital, Google Ventures, Deerfield, Nextech Invest.

Investor typeCountShare
Venture capital1348%
Private equity311%
Bank & private debt311%
Other / undisclosed830%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

31 Mar 2026 · Senior Director, Clinical Pharmacology & Pharmacometrics (CPP)

Based on job postings tracked across public sources.

Recent activity

16 Jun 2026
Milestone
regulatory
10 Jun 2026
Milestone
regulatory
18 May 2026
Partnership
Regeneron Pharmaceuticals
Coming soon